Tag: trial robustness

Handling Dropouts and Protocol Deviations in Clinical Trial Analysis

Posted on digi By digi

Handling Dropouts and Protocol Deviations in Clinical Trial Analysis How to Handle Dropouts and Protocol Deviations in Clinical Trial Analysis Dropouts and protocol deviations are almost inevitable in clinical trials. Whether due to patient withdrawal, non-adherence, or procedural inconsistencies, these events can distort the trial results if not properly handled. Regulators like the USFDA and…

Read More “Handling Dropouts and Protocol Deviations in Clinical Trial Analysis” »

Biostatistics in Clinical Research, Handling Missing Data

Sensitivity Analyses for Missing Data Assumptions in Clinical Trials

Posted on digi By digi

Sensitivity Analyses for Missing Data Assumptions in Clinical Trials How to Conduct Sensitivity Analyses for Missing Data Assumptions in Clinical Trials Missing data in clinical trials introduces uncertainty that can threaten the reliability of results. While primary analyses often assume missing at random (MAR), real-world data may violate this assumption. Sensitivity analyses are therefore essential…

Read More “Sensitivity Analyses for Missing Data Assumptions in Clinical Trials” »

Biostatistics in Clinical Research, Handling Missing Data

Assessing the Impact of Missing Data on Clinical Trial Outcomes

Posted on digi By digi

Assessing the Impact of Missing Data on Clinical Trial Outcomes How Missing Data Affects Clinical Trial Outcomes and What You Can Do About It Missing data in clinical trials isn’t just an inconvenience—it’s a major threat to the integrity of study outcomes. Whether it stems from patient dropout, loss to follow-up, or incomplete data collection,…

Read More “Assessing the Impact of Missing Data on Clinical Trial Outcomes” »

Biostatistics in Clinical Research, Handling Missing Data